The impact of telemonitoring on correct drug use, complications and quality of life among patients with multiple myeloma (ITUMM): A study protocol for an open-label, parallel-group, randomized controlled trial.
Job F H EijsinkPaul A F GeertsKarin KammingaMireille A EdensCornelis BoersmaMaarten J PostmaJan Gerard MaringPeter G J Ter HorstPublished in: PloS one (2024)
ClinicalTrials.gov number: NCT05964270 and ABR number: NL75771.075.20.